Índice

• • ·Meeting the need for germline testing

    Página :709

     
• • ·Triaging suspected cancer with a multi-cancer early detection blood test

    Página :710-711

    Jeanne Tie

     
• • ·Initially unresectable colorectal liver metastases: the best therapeutic regimens

    Página :711-713

    Katsunori Imai, Hideo Baba

     
• • ·Adjuvant chemotherapy in nasopharyngeal carcinoma

    Página :713-715

    Pui Lam Yip, Anne W M Lee, Melvin L K Chua

     
• • ·γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cells

    Página :715-717

    Alberto Mussetti, Anna Sureda

     
• • ·Adjuvant immune checkpoint blockade revisited

    Página :717-719

    Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, Simone Koole, Lonneke Timmers, Christian Blank, Hans Gelderblom

      
• • ·Dispensation for access to novel anticancer agents in France

    Página :719-720

    Dominique Levêque, Marine Beck, Mathieu Cotton

    
• • ·Endoscopic surveillance in hereditary diffuse gastric cancer

    Página :e285

    Kaso Ari, Sri Sivarajan, Jay J Park, Suheelan Kulasegaran, Bhaskar Kumar

    
• • ·Endoscopic surveillance in hereditary diffuse gastric cancer

    Página :e286

    James Tankel, Sheraz Markar, Marc van Berge Henegouwen, Lorenzo Ferri, Jonathan Cools-Lartigue

    
• • ·Endoscopic surveillance in hereditary diffuse gastric cancer

    Página :e287

    Massimiliano di Pietro, Judith Honing, Colin YC Lee, Rebecca C Fitzgerald

     
• • ·Endoscopic surveillance in hereditary diffuse gastric cancer – Authors’ reply

    Página :e288

    A Leila Sarvestani, Bilal Asif, Amber L Famiglietti, Louis Korman, Theo Heller, Jeremy L Davis

    
• • ·Adjuvant chemotherapy for locally advanced cervical cancer

    Página :e289

    Sezin Yuce Sari, Nur Nimet Saliha Akdag, Melis Gultekin, Ferah Yildiz

    
• • ·Adjuvant chemotherapy for locally advanced cervical cancer – Authors’ reply

    Página :e290

    Linda R Mileshkin, Kailash Narayan, David K Gaffney, Elizabeth H Barnes, Yeh Chen Lee, Bradley J Monk, Martin R Stockler

    
• • ·Correction to Lancet Oncol 2023; 24: e242

    Página :e291

    
• • ·Concern over cancer treatment delays caused by staffing shortages

    Página :721

    Elizabeth Gourd

     
• • ·World’s first alcohol health labelling policy to be introduced in Ireland

    Página :722

    Talha Burki

     
• • ·Organisations in Bangladesh urge for amendment in tobacco control bill

    Página :723

    Manjulika Das

     
• • ·2023 ASCO Annual Meeting

    Página :724-725

    Allison Landman

    Esquema Esquema  
• • ·Canada to put health warnings on individual cigarettes

    Página :726

    Tony Kirby

     
• • ·Cancer care critically affected by USA drug shortages

    Página :727

    Elizabeth Gourd

     
• • ·Syrian cancer patients regain treatment access in Türkiye

    Página :728

    Manjulika Das

     
• • ·Italy to pass law on the right to be forgotten for cancer survivors

    Página :e292

    Manjulika Das

     
• • ·Addressing the childhood cancer crisis in sub-Saharan Africa

    Página :729-732

    Joseph Lubega, Lulu Chirande, Barnabas Atwine, Alan Davidson, Heronima J Kashaigili, Aimable Kanyamuhunga, Robert K Langat, Deogratias Munube, Rizine Mzikamanda, Ruth Namazzi, Irene Nzamu, Anne Akullo, Carl Allen, Julie M Gastier-Foster, Marilyn Hockenberry, Nmazuo Ozuah, Peter Wasswa, Rachel Smith, Kristi Wilson-Lewis, David G Poplack

    Esquema Esquema  
• • ·Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study

    Página :733-743

    Brian D Nicholson, Jason Oke, Pradeep S Virdee, Dean A Harris, Catherine O’Doherty, John ES Park, Zaed Hamady, Vinay Sehgal, Andrew Millar, Louise Medley, Sharon Tonner, Monika Vargova, Lazarina Engonidou, Kaveh Riahi, Ying Luan, Sara Hiom, Harpal Kumar, Harit Nandani, Kathryn N Kurtzman, Ly-Mee Yu, Clare Freestone, Sarah Pearson, FD Richard Hobbs, Rafael Perera, Mark R Middleton

    Resumen Resumen Esquema Esquema   
• • ·Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

    Página :744-756

    Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, Ian Chau, Haeseong Park, Salvatore Siena, Sara Lonardi, Zev A Wainberg, Jaffer Ajani, Joseph Chao, Yelena Janjigian, Amy Qin, Jasmeet Singh, Ferdous Barlaskar, Yoshinori Kawaguchi, Geoffrey Ku

    Resumen Resumen Esquema Esquema   
• • ·First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

    Página :757-771

    Marinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, Jan Willem B de Groot, Helga Droogendijk, Helgi H Helgason, Mathijs P Hendriks, Joost M Klaase, Geert Kazemier, Mike S L Liem, Arjen M Rijken, Cornelis Verhoef, Johannes H W de Wilt, Koert P de Jong, Michael F Gerhards, Martinus J van Amerongen, Marc R W Engelbrecht, Krijn P van Lienden, I Quintus Molenaar, Bart de Valk, Brigitte C M Haberkorn, Emile D Kerver, Frans Erdkamp, Robbert J van Alphen, Daniëlle Mathijssen-van Stein, Aysun Komurcu, Marta Lopez-Yurda, Rutger-Jan Swijnenburg, Cornelis J A Punt, Dutch Colorectal Cancer Study Group, Thomas Van Gulik, Joost Huiskens, Harm Van Tinteren, Cornelis H.C. Dejong, Dirk J. Grünhagen, Gijs A. Patijn, Theo J.M. Ruers, Thiery Chapelle, John J. Hermans, Wouter K.G. Leclercq, Liselot B.J. Valkenburg-van Iersel, Cecile Grootscholten, Joyce M. Van Dodewaard-de Jong, Jeroen Vincent, Danny Houtsma, Maartje Los, Marien Den Boer, Marija Trajkovic-Vidakovic, Theo Van Voorthuizen, Miriam Koopman, Johanneke H.M.J.V. Vestjens, Hans Torrenga, Leonie J. Mekenkamp, Gerrit Jan Veldhuis, Marco B. Polee, Serge E. Dohmen, Heidi Schut, Annelie J.E. Vulink, Henk K. Van Halteren, Jamal Oulad Hadj, Pieter-Paul J.B.M. Schiphorst, Ronald Hoekstra

    Resumen Resumen Esquema Esquema   
• • ·Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    Página :772-782

    James J Harding, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui-Chuan Sun, Teresa Macarulla, Feng Xie, Jean-Phillippe Metges, Jie’er Ying, John Bridgewater, Myung-Ah Lee, Mohamedtaki A Tejani, Emerson Y Chen, Dong Uk Kim, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Lisa Boyken, Jiafang Ma, Phillip Garfin, Shubham Pant, HERIZON-BTC-01 study group, Ghassan Abou-Alfa, Jorge Adeva Alfonso, Massimo Aglietta, Ari Baron, Muhammad Beg, Paula Carrasco Aguirre, Eric Chen, Ying Cheng, Antonio Cubillo Gracián, Laetitia Dahan, Filippo De Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastian Mondaca, Andrés J. Muñoz Martin, Joon Oh Park, Roberto Pazo Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Rodriguez Alonso, Saeed Sadeghi, Aaron Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao

    Resumen Resumen Esquema Esquema   
• • ·Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials

    Página :783-797

    Claire L Vale, David J Fisher, Peter J Godolphin, Larysa H Rydzewska, Jean-Marie Boher, Sarah Burdett, Yu-Hui Chen, Noel W Clarke, Karim Fizazi, Gwenaelle Gravis, Nicholas D James, Glenn Liu, David Matheson, Laura Murphy, Robert E Oldroyd, Mahesh K B Parmar, Ewelina Rogozinska, Patrick Sfumato, Christopher J Sweeney, Matthew R Sydes, Bertrand Tombal, Ian R White, Jayne F Tierney, STOPCAP Collaboration

    Resumen Resumen Esquema Esquema   
• • ·Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

    Página :798-810

    Li-Ting Liu, Huai Liu, Ying Huang, Jin-Hao Yang, Si-Yi Xie, Yuan-Yuan Li, Shan-Shan Guo, Bin Qi, Xiao-Yun Li, Dong-Ping Chen, Feng Jin, Xue-Song Sun, Zhen-Chong Yang, Sai-Lan Liu, Dong-Hua Luo, Ji-Bin Li, Qing Liu, Pan Wang, Ling Guo, Hao-Yuan Mo, Fang Qiu, Qi Yang, Yu-Jing Liang, Guo-Dong Jia, Dong-Xiang Wen, Jin-Jie Yan, Chong Zhao, Qiu-Yan Chen, Rui Sun, Lin-Quan Tang, Hai-Qiang Mai

    Resumen Resumen Esquema Esquema   
• • ·γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

    Página :811-822

    Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till, Edward N Libby, David G Coffey, Sherilyn A Tuazon, Brent Wood, Ted Gooley, Vicky Q Wu, Jenna Voutsinas, Xiaoling Song, Mazyar Shadman, Jordan Gauthier, Aude G Chapuis, Filippo Milano, David G Maloney, Stanley R Riddell, Damian J Green

    Resumen Resumen Esquema Esquema   
• • ·Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

    Página :e293

    Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, Nelson Leung, Joseph Mikhael, Simon J Harrison, Efstathios Kastritis, Laurent Garderet, Alessandro Gozzetti, Niels W C J van de Donk, Katja C Weisel, Ashraf Z Badros, Meral Beksac, Jens Hillengass, Mohamad Mohty, P Joy Ho, Ioannis Ntanasis-Stathopoulos, Maria-Victoria Mateos, Paul Richardson, Joan Blade, Philippe Moreau, Jesus San-Miguel, Nikhil Munshi, S Vincent Rajkumar, Brian G M Durie, Heinz Ludwig, Evangelos Terpos, International Myeloma Working Group

    Resumen Resumen Esquema Esquema   
• • ·Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

    Página :e312

    Alessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, Luca Viganò, David J Pinato, Francesca Romana Ponziani, Quirino Lai, Andrea Casadei-Gardini, Ciro Celsa, Giovanni Galati, Martina Gambato, Laura Crocetti, Matteo Renzulli, Edoardo G Giannini, Fabio Farinati, Franco Trevisani, Umberto Cillo, HCC Special Interest Group of the Italian Association for the Study of the Liver, Umberto Baccarani, Giuseppina Brancaccio, Raffaele Cozzolongo, Alessandro Cucchetti, Nicoletta De Matthaeis, Stefano Di Sandro, Simone Famularo, Michele Finotti, Francesco G Foschi, Davide Ghinolfi, Marco Guarracino, Salvatore Gruttadauria, Maria Guarino, Alba Kostandini, Ilaria Lenci, Giovanni B Levi Sandri, Tommaso M Manzia, Giovanni Marasco, Mario Masarone, Chiara Mazzarelli, Fabio Melandro, Luca Miele, Filomena Morisco, Daniele Nicolini, Duilio Pagano, Filippo Pelizzaro, Giulia Pieri, Fabio Piscaglia, Maria Corina Plaz Torres, Riccardo Pravisani, Maria Rendina, Fabrizio Romano, Francesco P Russo, Rodolfo Sacco, Angelo Sangiovanni, Carlo Sposito, Raffaella Tortora, Francesco Tovoli, Mauro Viganò, Paola Violi

    Resumen Resumen Esquema Esquema   
• • ·Adenocarcinoma of lung presenting as diffuse interstitial lung disease

    Página :e323

    B Jayakrishnan, Ikram Burney, Anjum Hassan Osman, Sami M Bennji, Zamzam Al-Hashami